AURKB and cancer: Farrell et al. reported an Aurora B kinase inhibitor TAK-901 (88) (Farrell et al., 2013), which inhibited AurB/INCENP with an IC50 value of 15 nM and inhibited various human cancer cell lines with IC50 values ranging from 40 to 500 nM.